Prosecution Insights
Last updated: April 19, 2026

Slayback Pharma LLC

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19065403 PHARMACEUTICAL LIQUID COMPOSITIONS OF MELOXICAM PEEBLES, KATHERINE 1617 Final Rejection Feb 27, 2025
18487330 Stable Antiemetic Emulsions for Parenteral Administration MOU, LIYUAN 1628 Non-Final OA Oct 16, 2023
17822399 STABLE PHARMACEUTICAL COMPOSITIONS OF SUCCINYLCHOLINE CHLORIDE ISMAIL, REHANA 1625 Non-Final OA Aug 25, 2022

Managing Slayback Pharma LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month